Pharm Block 2 Kinetics Flashcards
Prednisone
PO doses from 5-100mg QD
Metabolized in the liver to prednisolone
t 1/2 ~ 18-36 hr
Cyclosporine
PO or IV for immunosuppression at 2.5-15 mg/kg QD; narrow therapeutic window
Opthalmic formulation 0.05% or 0.1% is used to increase tear production that has been suppressed by inflammation
CYP3A4 (drug interactions!); metabolites excreted in bile
Tacrolimus
IV or PO; PO absorption is highly variable (needs individualized regimens)
Extensively metabolized by CYP3A4 (drug interactions!)
Metabolites excreted in bile
Concentrated in the pancreas and may INHIBIT PANCREATIC INSULIN SECRETION
Sirolimus
Solution or tablets for PO administration (2-5 mg QD)
Cypher is a sirolimus-eluting stent used to inhibit restenosis after stenting to treat coronary artery occlusion; 80% of sirolimus is released in 30 days and the rest in 90 days
CYP3A4 substrate (drug interactions!) Metabolites excreted in bile
Long t 1/2 - 60 hrs
Azathioprine
PO or IV, good oral absorption
Maintenance does is 1-3 mg/kg QD
6-MP is inactivated by oxidation (by xanthine oxidase) and methylation (by thiopurine S-methyltransferase)
Excretion is mostly renal
Mycophenolate mofetil
PO or IV; both routes offer essentially complete bioavailability of mycophenolic acid
Usual dose is 1g BID for kidney and liver transplants, 1.5 g BID for heart transplants
Inactive phenolic glucuronide is main metabolite; excreted almost entirely in urine
Muromonab-CD3
1 mg/mL solution for IV bolus administration
Usual does is 5 mg QD for 10-14 days
T cells begin to disappear from blood within minutes and reappear 1 week after therapy is halted
Basiliximab
Lyophilized powder that is reconstituted for IV administration
20 mg given IV as bolus injection or infusion over 20-30 min
First 20 mg dose given 2 hr prior to surgery
Second 20 mg dose is given 4 days after transplantation
Elimination half-life is 7 days; normal T cell numbers return in 7-14 days
Adalimumab
Prefilled syringes containing 20 or 40 mg for SC injection
Maintenance dose is 40 mg Q 2 weeks
Elimination half-life is 10-20 days (mean 14 days)
Carbachol
0.01% solution that is instilled into anterior chamber of the eye
Miosis is maximal 2-5 min after administration
Not susceptible to AChE inactivation
Duration of miosis - 24 hrs
Methacholine
Lyophilized powder is reconstituted in isotonic saline for inhalation via nebulizer
3-fold more resistant to AChE than acetylcholine
Most subjects return to baseline pulmonary function after 30-45 min
Bethanechol
PO tablets 10-50 mg TID-QID
Onset occurs 60-90 min and duration is 60 min
Not susceptible to AChE inactivation
Pilocarpine
0.5-6% opthalmic solution, duration 4-14 hrs
PO dose 5-10 mg TID, 3-5 hr duration
Ocusert delivers pilocarpine for 7 days via contact lens-like system
Nicotine
Gum, lozenge, inhaler, nasal spray, transdermal patch
Widely distributed in body tissues, especially CNS
Mostly metabolized in liver; unchanged nicotine and metabolites are excreted by kidney
t 1/2 = 30-120 min
Varenicline
0 .5 mg and 1 mg tablets for PO, usually 1 mg BID after 1 week ramp-up
Peak plasma concentration reached in 3-4 hr; half-life = 24 hr
Minimal metabolism, 92% is excreted unchanged in urine
Physostigmine
0.1% solution via IV injection or applied topically to eye
Duration of action 1-2 hr when given IV, 12-36 hr on eye
Neostigmine
15 mg tablets for PO
Average dose is 10 tabs QD with individualized dosing interval
Duration of action 2-4 hr
Edrophonium
IV or IM
Duration of action ranges from 5-10 min (IV) and 5-30 min (IM)
Echothiophate
0.03% topical opthalmic solution, 1 qtt QD-BID
Membrane penetration is poor due to high polarity
Duration of action = 100hr
Pralidoxime
1-2g IV, PO, IM
Infuse in 100mL of saline given over 15-30 min with additional doses PRN
Distributes throughout extracellular water
Metabolized by liver with half-life of 74-77 min
Both unchanged drug and metabolite are excreted by kidneys
Atropine
PO tabs or IV, IM or SC solution
0.5-1 mg as antisialagogue, 2-3mg for AChE inhibitor or muscarinic agonist poisoning
Well absorbed, widely distributed throughout body
Metabolized in liver
t 1/2 = 2-4 hr
Excreted renally
Oxybutynin
Topically (transdermal patch) or PO (5mg BID-TID)
Widely distributed to body tissues
Onset within 30-60 min of PO, duration 6-10 hrs
CYP3A4 (enteric and hepatic)
Ipratropium
Oral inhalation or 0.03% nasal spray
Effect lasts 4-6 hrs
Quaternary amine, doesn’t cross BBB very well
Mecamylamine
PO as 2.5 mg tablets, daily dose 2.5-25mg given TID or QID
Almost completely absorbed and excreted unchanged in urine
Epinephrine
IV or intracardiac injection, inhalation, topically to eye
Poor PO availability; metabolized by COMT and MAO in liver and other tissues
Duration varies, generally 1-4 hrs
Phenylephrine
Injection, PO, intranasally, opthalmically
Metabolized by MAO in liver and other tissues
Active for 30 min to 4 hr
Clonidine
Epidurally, PO, transdermal patch
PO bioavailability near 100%
Highly lipid soluble, distributes widely throughout the tissues including CNS
Antihypertensive effects last up to 8hrs (PO) and up to 7 days with transdermal patch
Isoproterenol
For cardiac arrests, IV infusion or IV bolus
For bronchodilation, aerosol
COMT metabolism